LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Droplet Digital PCR Rapidly Detects Alpha-Thalassemia Variants

By LabMedica International staff writers
Posted on 24 Aug 2016
Print article
Image: The QX100 Droplet digital PCR reader (Photo courtesy of Bio-Rad).
Image: The QX100 Droplet digital PCR reader (Photo courtesy of Bio-Rad).
Alpha (α)-thalassemia is a highly prevalent genetic disease worldwide and it is characterized by various degrees of alpha globin chain deficit caused by either deletional or non-deletional mutations although the former are more common.

Recently, there have been more reported cases of rare α-thalassemia mutations due to the advancement of molecular techniques involved in thalassemia detections. Therefore, it is essential to develop a new method, which allows the detection of different α-thalassemia mutations including the rare ones simultaneously and accurately.

Scientists at the University Putra Malaysia (Serdang, Malaysia) designed an assay for the detection of triplications, common and rare deletional α-thalassemia using droplet digital PCR (ddPCR). Eleven archived DNA samples with known genotypes and one DNA sample with heterozygous deletion spanning from HS-40 region to alpha1 globin region were used in the study.

Four copy number variations (CNV) assays were carried out in duplications for each sample, which includes the upstream alpha globin regulatory element HS- 40, Hemoglobin, alpha 2 (HBA2), HBA3.7 and HBA1 genes. A total of 20 µL of each polymerase chain reaction (PCR) mixture was loaded into a sample well of a DG8TM Cartridge for QX100 Droplet Generator (Bio-Rad Laboratories, Hercules, CA, USA), followed by 70 µL of droplet generation oil into the oil wells. After the thermal cycling process, the sealed 96-well plate was placed in the Bio-Rad QX100 Droplet Digital Reader.

The team found that found that the use of ddPCR is convenient as it allows direct quantification without the requirement of a calibration curve unlike quantitative PCR. They showed that showed that ddPCR is accurate and precise in the detection of alpha thalassemia deletions and triplications based on the gene dosages using absolute quantification. Twelve samples with different α-thalassemia deletions at different regions located at HS-40 to HBA1 and triplications of α-globin genes were detected accurately. The investigators also showed that ddPCR saves time with less turnaround time and minimize the labor work required as compared to other techniques. The study was published in the August 2016 issue of the International Journal of Laboratory Hematology.

Related Links:
University Putra Malaysia
Bio-Rad Laboratories
Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.